+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Equine Healthcare Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4749558
  • Report
  • Region: Global
  • Acute Market Reports
1 of 3

FEATURED COMPANIES

  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Eli Lilly and Company
  • Equine Products U.K. Ltd.
  • Vetoquinol S.A.
  • Zoetis
  • MORE
The global equine healthcare market was valued at US$ 626.2 Mn in 2017 expanding at a CAGR of 4.0% from 2018 to 2026.

Market Insights:

Horses are considered sports animals, companion animals, and working animals and provide employment and income in many developed and developing countries. According to Equine Business Association (EBA), the U.S. and U.K are the biggest equine industries in the world. There are more than 446,000 horse-owning households in the U.K. itself. Moreover, in China horse clubs has increased around 1500% in recent years from 90 in 2010 to 1400 in 2017. Thus, this growth in the horse racing and equine shows and leisure events have skyrocketed the demand for equine healthcare market and projected to grow during the forecast period. Presence of major pharmaceutical players in the market such as Boehringer Ingelheim, Bayer AG, Merck & Co., Zoetis has made the market highly competitive by continuous innovation in the products. Moreover, growing demand for equine insurance in the developed countries will further drive the market. However, legislation on horse racing will hinder the market during the forecast period. In terms of disease type, the market is segmented into West Nile Virus, Potomac horse fever, equine rabies, tetanus, equine influenza, and equine herpes virus. Tetanus and West Nile Virus are some of the most prevalent diseases and expected to account for high market share in the market. Growing incidences of equine influenza, equine herpesvirus, and rabies during the forecast period will further provide market growth.

In terms of geography, North America held the largest share in the global equine healthcare market. Increasing popularity for horse racing, high equine adoption rate in the household and substantial spending on animal healthcare are the major growth factors. Around 7 million Americans are directly involved in the equine industry and more than 2 million are horse owners. Europe emerged as the second largest equine healthcare market due to mounting demand for equine healthcare products in the region. The Asia Pacific is projected to grow at the fastest growth rate during the forecast period. The growing focus of animal care in the region, rising affordability and awareness of equine healthcare products in countries such as China, India, and Australia would boost the market. The key players currently engaged in equine healthcare market include Zoetis, Bayer AG, Boehringer Ingelheim (Merial), Vetoquinol S.A., Purina Animal Nutrition LLC, Merck & Co. (Merck Animal Health) among others. In January 2017, Boehringer Ingelheim and Sanofi exchanged Boehringer Ingelheim’s consumer healthcare (CHC) business and Sanofi’s animal health business (Merial) with each other to gain market dominance in respective fields.

Key Market Movements:
  • The growing popularity of horse racing in developed and developing regions
  • Growing awareness and affordability of equine healthcare products
  • Strict regulations associated with horse racing and horse breeding activities
  • The dominance of North America and Europe in an equine healthcare market
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Eli Lilly and Company
  • Equine Products U.K. Ltd.
  • Vetoquinol S.A.
  • Zoetis
  • MORE
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Equine Healthcare Market Portraiture
2.2. Global Equine Healthcare Market, by Product Type, 2017 (US$ Mn)
2.3. Global Equine Healthcare Market, by Disease Type, 2017 (US$ Mn)
2.4. Global Equine Healthcare Market, by Geography, 2017 (US$ Mn)

Chapter 3. Equine Healthcare: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Equine Healthcare Market, by Key Players, 2017

Chapter 4. Global Equine Healthcare Market, by Product Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Drug Type
4.2.1. Anti-Infective
4.2.2. Anti-Inflammatory
4.2.3. Parasiticides
4.2.4. Others
4.3. Vaccine Type
4.3.1. Inactivated
4.3.2. Live Attenuated
4.3.3. Recombinant
4.3.4. Others
4.4. Supplements and Additives

Chapter 5. Global Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. West Nile Virus
5.3. Equine Rabies
5.4. Potomac Horse Fever
5.5. Tetanus
5.6. Equine Influenza
5.7. Equine Herpes Virus

Chapter 6. Global Equine Healthcare Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America Equine Healthcare Market Analysis, 2016 – 2026
6.1.1. North America Equine Healthcare Market, by Product Type, 2016 - 2026 (US$ Mn)
6.1.2. North America Equine Healthcare Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.1.3. North America Equine Healthcare Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe Equine Healthcare Market Analysis, 2016 – 2026
6.2.1. Europe Equine Healthcare Market, by Product Type, 2016 - 2026 (US$ Mn)
6.2.2. Europe Equine Healthcare Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.2.3. Europe Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific Equine Healthcare Market Analysis, 2016 – 2026
6.3.1. Asia Pacific Equine Healthcare Market, by Product Type, 2016 - 2026 (US$ Mn)
6.3.2. Asia Pacific Equine Healthcare Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.3.3. Asia Pacific Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. Rest of Asia Pacific
6.4. Latin America Equine Healthcare Market Analysis, 2016 – 2026
6.4.1. Latin America Equine Healthcare Market, by Product Type, 2016 - 2026 (US$ Mn)
6.4.2. Latin America Equine Healthcare Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.4.3. Latin America Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa Equine Healthcare Market, 2016 – 2026
6.5.1. Middle East & Africa Equine Healthcare Market, by Product Type, 2016 - 2026 (US$ Mn)
6.5.2. Middle East & Africa Equine Healthcare Market, by Disease Type, 2016 - 2026 (US$ Mn)
6.5.3. Middle East & Africa Equine Healthcare Market, by Region, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa

Chapter 7. Company Profiles
7.1. Bayer AG (Bayer Animal Health)
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Boehringer Ingelheim
7.3. Ceva Sante Animale
7.4. Eli Lilly and Company
7.5. Equine Products U.K. Ltd.
7.6. Merck & Co. (Merck Animal Health)
7.7. Purina Animal Nutrition LLC
7.8. Vetoquinol S.A.
7.9. Zoetis

List of Figures
FIG 1. Equine Healthcare Market: Research Methodology
FIG 2. Equine Healthcare: Market Segmentation
FIG 3. Global Equine Healthcare Market, by Product Type, 2017 (US$ Mn)
FIG 4. Global Equine Healthcare Market, by Disease Type, 2017 (US$ Mn)
FIG 5. Global Equine Healthcare Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global Equine Healthcare Market, by Key Players, 2017
FIG 8. Global Anti-Infective Market in Equine Healthcare, 2016-2026 (US$ Mn)
FIG 9. Global Anti-Inflammatory Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 10. Global Parasiticides Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 11. Global Other Drugs Market kin Equine Healthcare, 2016-2026(US$ Mn)
FIG 12. Global Inactivated Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 13. Global Live Attenuated Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 14. Global Recombinant Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 15. Global Other Vaccines Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 16. Global Supplement and Additives Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 17. Global West Nile Virus Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 18. Global Equine Rabies Disease Market in Equine Healthcare , 2016-2026(US$ Mn)
FIG 19. Global Potomac Horse Fever Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 20. Global Tetanus Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 21. Global Equine Influenza Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 22. Global Equine Herpes Virus Disease Market in Equine Healthcare, 2016-2026(US$ Mn)
FIG 23. U.S. Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 24. Canada Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 25. U.K. Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 26. Germany Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 27. Rest of Europe Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 28. China Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 29. Japan Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 30. Rest of Asia Pacific Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 31. Brazil Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 32. Mexico Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 33. Rest of Latin America Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 34. GCC Equine Healthcare Market, 2016-2026 (US$ Mn)
FIG 35. Rest of Middle East & Africa Equine Healthcare Market, 2016-2026 (US$ Mn)

List of Tables
TABLE 1 Global Equine Healthcare Market Portraiture
TABLE 2 Global Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Drug Type in Equine Healthcare Market, 2016 – 2026 (US$ Mn)
TABLE 4 Global Vaccine Type in Equine Healthcare Market, 2016 – 2026 (US$ Mn)
TABLE 5 Global Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 6 Global Equine Healthcare Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 7 North America Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 8 North America Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 9 North America Equine Healthcare Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 11 Europe Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 12 Europe Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 17 Latin America Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America Equine Healthcare Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East & Africa Equine Healthcare Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 20 Middle East & Africa Equine Healthcare Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 21 Middle East & Africa Equine Healthcare Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 22 Bayer AG (Bayer Animal Health): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Ceva Sante Animale: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Equine Products U.K. Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Merck & Co. (Merck Animal Health): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Purina Animal Nutrition LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Vetoquinol S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Zoetis: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bayer AG (Bayer Animal Health)
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Eli Lilly and Company
  • Equine Products U.K. Ltd.
  • Merck & Co. (Merck Animal Health)
  • Purina Animal Nutrition LLC
  • Vetoquinol S.A.
  • Zoetis
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4749558
Adroll
adroll